BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 9, 2010
View Archived Issues
Irinotecan/S-1 active in 5-FU-resistant bladder cancer cell lines
Read More
Fast-dissolving desmopressin is safe in adults with nocturia
Read More
Two placebo-controlled trials show safety of CX-157
Read More
New GABA(A) receptor modulators claimed by NeuroSearch
Read More
Merck & Co. discloses new FABP inhibitors
Read More
Merck & Co. describes new gamma-secretase modulators
Read More
Nycomed presents new PDE4B inhibitors
Read More
Arbaclofen placarbil improves sleep quality in PPI-responsive GERD
Read More
Antitumor agent MSC-1936369B shows safety in phase I trial
Read More
NTx described as biomarker for prediction of bone metastasis in lung cancer
Read More
Bortezomib linked to heart failure in patients with multiple myeloma
Read More
PTC receives award to develop anticancer drugs targeting BMI-1
Read More
Merck Serono resubmits cladribine tablets NDA for relapsing MS to FDA
Read More
Benlysta MAA submitted to EMA for SLE
Read More
Can-Fite opens new CF-101 IND with phase II/III trial protocol in psoriasis
Read More
VIVUS' avanafil improves ED in phase III trial in diabetic men
Read More
Auxilium reports 2-year recurrence data on Xiaflex
Read More
AVI BioPharma and DTRA enter into new contract for AVI-7100
Read More
Phico Therapeutics' PT1.2 safe and well tolerated in phase I trial
Read More
Zealand Pharma and sanofi-aventis extend lixisenatide licensing agreement
Read More
Telik reports phase II data on ezatiostat in MDS
Read More
Adeona advances enrollment in part 2 of CopperProof-2 trial in AD
Read More
Immunovaccine and Vaxil join to advance potential cancer vaccine
Read More
Cellceutix expedites studies of KM-391 and Kevetrin
Read More
Opal Therapeutics and MGH to jointly develop HIV vaccine
Read More